Edwards Lifesciences Corp (NYSE:EW)

135.95
Delayed Data
As of May 25
 -1.62 / -1.18%
Today’s Change
100.20
Today|||52-Week Range
143.22
+20.62%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$29.1B

Company Description

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Critical Care portfolio products hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA..

Contact Information

Edwards Lifesciences Corp.
One Edwards Way
Irvine California 92614
P:(949) 250-2500
Investor Relations:
(949) 250-6826

Employees

Shareholders

Mutual fund holders45.85%
Other institutional38.60%
Individual stakeholders1.44%

Top Executives

Michael A. MussallemChairman & Chief Executive Officer
Scott B. UllemChief Financial Officer & Vice President
Stanton J. RoweChief Scientific Officer & VP-Advanced Technology
John P. McGrathVice President-Quality, Regulatory & Clinical
Aimee S. WeisnerVice President & General Counsel